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PHeart Failure
he Diagnosis of Heart Failure in the Community
omparative Validation of Four Sets of Criteria in
nselected Older Adults: The ICARe Dicomano Study
auro Di Bari, MD, PHD,*† Claudia Pozzi, MD,* Maria Chiara Cavallini, MD, PHD,*†
rancesca Innocenti, MD,*† Giorgio Baldereschi, MD,*† Walter De Alfieri, MD,‡ Enrico Antonini, MS,*
iccardo Pini, MD, FACC,*† Giulio Masotti, MD,*† Niccolò Marchionni, MD*†
lorence and Grosseto, Italy
OBJECTIVES We sought to compare construct and predictive validity of four sets of heart failure (HF)
diagnostic criteria in an epidemiologic setting.
BACKGROUND The prevalence estimates of HF vary broadly depending on the diagnostic criteria.
METHODS Data were collected in a survey of community dwellers who were 65 years of age living in
Dicomano, Italy. At baseline, HF was diagnosed with the criteria of the Framingham,
Boston, and Gothenburg studies and of the European Society of Cardiology (ESC). Left
ventricular mass index and ejection fraction, left atrium systolic dimension, lower extremity
mobility disability, summary physical performance score, and 6-min walk test were compared
between HF and non-HF participants to test for construct validity of each set of criteria.
Predictive validity was evaluated with follow-up assessment of cardiovascular mortality,
incident disability, and HF-related hospitalizations. Comparisons were adjusted for demo-
graphics, comorbidity, and psychoaffective status.
RESULTS Of 553 participants, 11.9%, 10.7%, 20.8%, and 9.0% had HF, according to Framingham, Boston,
Gothenburg, and ESC criteria, respectively. In terms of construct validity, Framingham and
Boston criteria discriminated HF from non-HF participants better than Gothenburg and ESC
criteria across the measures of cardiac function and global performance. The Boston criteria
showed a superior predictive validity because they indicated a significantly greater adjusted risk of
cardiovascular death (hazard ratio 3.9, 95% confidence interval 1.2 to 13.2), incident disability, and
hospitalizations in participants with HF.
CONCLUSIONS The Boston criteria are preferable to Framingham, Gothenburg, and ESC criteria for the
diagnosis of HF in older community dwellers because they have good construct validity and
more accurately predict cardiovascular death, incident disability, and hospitalizations. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.07.022Coll Cardiol 2004;44:1601–8) © 2004 by the American College of Cardiology Foundation
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teart failure (HF) poses a major burden on public health
ystems of industrialized countries. Its prevalence and inci-
ence sharply increase in older individuals (1,2), in whom
his condition is a leading cause of death, morbidity,
isability, and hospital admissions (3–5). However, ran-
omized clinical trials of angiotensin-converting enzyme
nhibitors (6), angiotensin receptor antagonists (7), beta-
lockers (8), and spironolactone (9) have clearly shown that
urvival and functional outcomes can be effectively improved
hen HF is recognized in a timely manner.
Unfortunately, the clinical recognition of HF can be
ifficult, especially at a primary care level. Even experienced
hysicians frequently disagree on the diagnosis of mildest
ases (10), whereas50% of the diagnoses made by primary
are physicians are confirmed after further cardiac assess-
From the *Department of Critical Care Medicine and Surgery, Unit of Gerontol-
gy and Geriatrics, University of Florence, and †Azienda Ospedaliero-Universitaria
areggi, Florence, Italy; and ‡Unit of Geriatrics, Grosseto, Italy. Sponsored in part
y the Italian Ministry of Scientific and Technological Research (National Special
roject on Heart Failure), by the Regional Government of Tuscany, and by the
zienda Ospedaliera Careggi-Firenze, Italy.m
Manuscript received April 16, 2004; revised manuscript received June 24, 2004,
ccepted July 5, 2004.ent (11). Because of comorbidity and atypical clinical
anifestations, the diagnosis is particularly challenging in
lder persons: a recent study reported that primary care
hysicians often feel uncomfortable in diagnosing HF and
n differentiating it from other diseases that are common in
ate life (12). Thus, the syndrome remains unrecognized and
oorly managed in many older patients (12).
Besides clinical practice, difficulties in the diagnosis of
F also impact on its epidemiologic assessment in the
opulation. Prevalence figures reported in the medical
iterature vary widely (13–17), mainly because different sets
f diagnostic criteria have been used. Most of these criteria
arely have been comparatively evaluated and, therefore, it is
nknown which set provides the most accurate estimates.
he present study was conducted to compare construct and
redictive validity of four established sets of criteria for the
iagnosis of HF in unselected older community dwellers.
ETHODS
n the validation process of a diagnostic instrument, the
erm construct validity indicates the ability of that instru-
ent to represent characteristics (constructs) of the condi-
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Validation of Heart Failure Diagnosis in the Elderly October 19, 2004:1601–8ion under examination, whereas predictive validity is the
bility of the instrument to predict clinically relevant out-
omes (18). In this study, HF constructs were considered
bnormalities in cardiac structure and function that are
ypical of the syndrome and limitations in physical perfor-
ance that are its ultimate consequences. Predictive validity
as evaluated by comparing cardiovascular mortality, hos-
ital admissions, and incident disability in subjects with and
ithout the diagnosis of HF.
tudy population and protocol. Data were obtained in the
Insufficienza Cardiaca negli Anziani Residenti a Dico-
ano” (ICARe Dicomano) Study, a longitudinal epidemi-
logic survey on HF in the elderly that was conducted in
icomano, a small rural town near Florence, Italy. The
ethods of the study have been previously detailed (19,20).
riefly, the ICARe Dicomano Study, which is consistent
ith the principles of the Declaration of Helsinki on clinical
esearch involving human subjects, enrolled in 1995 the
ntire unselected, community-dwelling elderly (65 years)
opulation recorded in the City Registry Office. The only
xclusion criterion was living in a nursing home.
In a follow-up study, the City Registry Office was
onsulted to define vital status. Causes of death were
scertained from the International Classification of
iseases-9th edition-coded death certificates and structured
uestionnaires, which were answered by primary care phy-
icians. Deaths due to International Classification of Dis-
ases codes 410 (myocardial infarction), 430 to 438 (stroke),
nd 428 (HF) were considered cardiovascular deaths. Clin-
cal data were obtained by interviewing survivors and their
rimary care physicians.
ata collection. After informed consent, multidimen-
ional, geriatric assessment data, including complete clinical
xamination, physical performance tests, 12-lead electrocar-
iogram, and echocardiography, were collected at baseline.
iagnosis of HF. The diagnosis of HF was based on four
reviously published instruments: Framingham (16), Boston
21), and Gothenburg criteria (22) and the European Society
f Cardiology (ESC) principles (23), as operationalized by
avies et al. (14) and Fischer et al. (24).
Abbreviations and Acronyms
BADL  basic activities of daily living
ESC  European Society of Cardiology
GDS  Geriatric Depression Scale
HF  heart failure
ICED  Index of Coexisting Diseases
LASD  left atrial systolic dimension
LEMD  lower extremity mobility disability
LV  left ventricular
LVEF  left ventricular ejection fraction
LVMI  left ventricular mass index
MMSE  Mini Mental State Examination
SPS  summary performance score
6MWT  6-min walk testPreliminarily, the presence of dyspnea as the main symp- pom limiting physical activity was investigated using Gold-
an’s Specific Activity Scale (25), which explores tolerance
o exertion in standardized daily activities, grouped into four
lasses according to the level of energy expenditure in
etabolic equivalents (METS), from 7 (class I) to 2
ETS or at rest (class IV). The occurrence of orthopnea,
aroxysmal nocturnal dyspnea, and pulmonary edema also
as recorded.
With the Framingham instrument (16), HF was diag-
osed in the presence of two major or one major and two
inor criteria, representing signs and symptoms typical of
F. Circulation time 25 s, reduced vital capacity, and
eight loss after diuretics, which were enlisted in the
riginal Framingham diagnostic tool, were not considered
n this study.
The Boston instrument (21) explores the presence of
ymptoms and signs typical of HF in the three categories of
istory, physical findings, and chest X-ray. A score of 0 to
is assigned to each category, providing a summary score
rom 0 to 12 (Appendix). The original distinction between
definite (score 8) and a probable (score 5 to 7) diagnosis
f HF was not maintained in this study, where a score 5
as considered as diagnostic. Chest X-ray was not per-
ormed when the sum of scores assigned to history and
hysical findings was either 0 or 5 because in these two
xtremes chest X-ray alone would have allowed neither to
stablish nor to exclude the diagnosis. When indicated,
hest X-ray was scored independently by a cardiologist and
pulmonologist; disagreement (10% of cases) was re-
olved by consensus.
Gothenburg criteria (22) take into account history and
hysical findings to calculate a cardiac score contributing to
efine, together with specific drug treatment, an HF stage,
anging from 0 (HF absent) to 4 (death due to HF). In this
tudy, a diagnosis of HF based on this instrument was
ssigned only to participants resulting to have “overt HF”
stages 2 to 3). Stage 4, which can be assigned only in
ollow-up studies, was not applicable at baseline in the
resent investigation.
The ESC principles require a combination of symptoms,
bjective evidence of cardiac dysfunction, and response to
reatment in doubtful cases (23). As suggested by the ESC,
chocardiography was used to assess the presence of cardiac
ysfunction (see the next section). In agreement with Davies
t al. (14), reduced left ventricular ejection fraction (LVEF,
), valve dysfunction, and atrial fibrillation were considered
ardiac abnormalities supporting the diagnosis. Isolated
iastolic abnormality also was taken into account (24) to
cknowledge the possible occurrence of HF with preserved
ystolic function (24,26). Combining Davies’ categories of
efinite and probable HF (14), the ESC diagnosis was
ssigned to participants with dyspnea (Specific Activity
cale classification 2) and echocardiographic evidence of
ardiac dysfunction.
chocardiographic examination. Echocardiography was
erformed with a mechanical sector scanner (Challenger,
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iomedica, Genoa, Italy) according to standard methods
27,28). Images were videotaped and stop frames were
igitized (TomTecP90 System, TomTec Imaging Systems,
unich, Germany) for quantitative analysis by examiners
ho were blinded to clinical data. At least three measures
ere averaged in participants in sinus, and five in those in
on-sinus rhythm.
Technical acceptability of M-mode images was judged by
tandardized criteria (29). When M-mode orientation was
uboptimal, linear measures were taken from two-
imensional images. Left ventricular (LV) mass was calcu-
ated from LV wall thickness and internal dimensions (30)
nd indexed by body surface area (left ventricular mass index
LVMI], g/m2).
The LV volumes were calculated with the area-length
ormula, from manually traced endocardial end-diastolic
nd end-systolic borders from apical four-chamber view
mages. When this view was unavailable, volumes were
alculated with Teichholz’s formula from M-mode mea-
ures (31). An LVEF 50% was considered as indicative of
ystolic dysfunction.
Valvular and LV diastolic function was assessed with
olor, pulsed-wave, and continuous-wave Doppler signals.
ortic stenosis with peak gradient 20 mm Hg, mitral
tenosis with area 1.5 cm2, or regurgitant lesions 2/4
ere considered significant valve abnormalities. Peak early
nd late velocities were measured from the pulsed-wave
oppler mitral inflow pattern recorded at the mitral leaflet
ips. Isovolumetric relaxation time was measured as the time
nterval between the end of aortic outflow and the beginning
f mitral inflow signal. Isolated diastolic abnormality was
uggested in the presence of an LVEF 45% associated
ith an early/late ratio less than or an isovolumetric relax-
tion time greater than the age-appropriate limits of 0.50
nd 105 ms, respectively (32).
unctional assessment. Because HF impairs blood supply
o performing skeletal muscles, functional assessment was
onsidered a relevant component in the evaluation of
onstruct validity of the criteria for the diagnosis of HF.
Baseline functional status was assessed subjectively in
erms of self-reported lower extremity mobility disability
LEMD) and objectively by using performance tests. A
odified version of the World Health Organization disabil-
ty questionnaire (33) was used to identify LEMD as
ifficulty in one or more of six activities involving lower
xtremity function (transferring in and out of bed, using the
oilet, moving in the house, bathing or showering, walking
quarter of mile, climbing stairs) that are pivotal to
aintain autonomy in late life (34,35). The number of items
n which the participant reported difficulty was taken as a
ubjective measure of functional limitation.
Objective measures of functional status were the 6-min
alk test (6MWT) (36) and a modified version of Gu-
alnik’s lower extremity physical performance battery (37).
tudies have shown that the distance (m) walked in the nMWT is a strong prognostic predictor in HF and other
linical conditions (36). The lower extremity physical per-
ormance battery is a tool well established in comprehensive
eriatric assessment, which includes three tests assessing
alance, a walk of short distance, and lower extremity
trength (37). Balance is evaluated as the time, up to a
aximum of 10 s, the participant is able to maintain
tanding equilibrium in five tasks of increasing difficulty.
alking ability is assessed as speed in a 4-m path, taking
he best result in two trials. Lower extremity strength is
ndirectly evaluated as time required to stand up five times
rom a chair. The performance is evaluated by assigning to
ach test a score from 0 (worst performance) to 4 (best
erformance) based on the quartile distribution of the test
esults in a reference older population. A summary perfor-
ance score (SPS, range 0 to 12) is then calculated as the
um of individual test scores. The SPS predicts important
utcomes such as incident physical disability, nursing home
dmission, and death (37).
In survivors who were not disabled at baseline, incident
isability in basic activities of daily living (BADL) was
valuated in the follow-up as onset of need for help in at
east one of the following: walking in the house, washing
nd dressing self, toileting, transferring from bed to chair,
nd eating (33).
ssessment of comorbidity. The previously described
easures of functional status are nonspecific for HF and can
e influenced by noncardiac diseases. Thus, they can be used
o validate a diagnosis of HF only when other causes of
unctional limitation are accounted for in multivaried anal-
ses. To this purpose, comorbidities were thoroughly ascer-
ained and quantified.
Diagnostic algorithms, based on questionnaires, physical
xamination, laboratory tests, and instrumental data (19),
ere used to identify 14 coexisting diseases. The individual
isease severity was weighted using Greenfield’s index,
hich ranges from 0 (disease absent) to 4 (life threatening
r uncontrolled disease). The burden of comorbidity was
hen summarized as Index of Coexisting Diseases (ICED),
hich is the sum of the individual severity scores (38).
Cognitive impairment and depressive symptoms, which
re frequent non-somatic comorbidities of late life not
ncluded in the ICED, were evaluated with the Mini
ental State Examination (MMSE) (39) and the Geriatric
epression Scale (GDS) (40).
nalytic procedures. Statistical analysis was performed with
PSS for Windows 10.1 (SPSS Inc., Chicago, Illinois). Con-
inuous variables are reported as mean  SEM. Relative
requencies were compared with the chi-squared test. Kappa
tatistics was used to analyze the agreement between pairs of
ets of diagnostic criteria.
To evaluate construct validity, measures of cardiac struc-
ure and function (LVMI, LVEF, and left atrial systolic
imension [LASD]) and global functional status (LEMD,
MWT, and SPS) were compared between HF and
on-HF participants in age-adjusted and gender-adjusted
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Validation of Heart Failure Diagnosis in the Elderly October 19, 2004:1601–8nalysis of variance models. The Index of Coexisting Dis-
ases, MMSE, and GDS scores were also entered as
ovariates in models analyzing differences in functional
tatus.
Predictive validity was evaluated by comparing cardiovas-
ular mortality, incident BADL disability, and HF-related
ospitalizations between HF and non-HF participants.
ox’s proportional hazards survival model was used to
nalyze cardiovascular mortality. The proportionality of
azards was assessed with visual inspection of the survival
urves. Logistic regression was used to analyze the risk of
ncident BADL disability and hospital admission. In all
nalyses, age, gender, and ICED, MMSE, and GDS scores
ere entered as covariates. A two-tailed p value  0.05 was
onsidered statistically significant.
ESULTS
f 864 subjects eligible as of April 25, 1995, 614 underwent
ardiologic examination. Reasons for nonparticipation were
eath or nursing home admission before data collection in 21
ases and refusal in 229. After exclusion of another 61
articipants with incomplete data, the final study sample
ncluded 553 participants (64.0% of the original cohort), of
hom 232 (41.9%) were men. Mean age was 73.0 0.3 years
range, 65 to 94 years). Compared with the 553 participants
ncluded, those who were not included were older (76.1 0.4
ears; p 0.001) but had a similar proportion of men (45%; p
0.383). In most eligible nonparticipating (286 of 311) and
articipating subjects (538 of 553), clinical data could be
btained from primary care physicians, who reported a diag-
osis of HF less frequently in those who did participate (56 of
38; 10.4%), as compared with those who did not (59 of 286,
0.6%; p  0.001).
revalence of HF and diagnostic concordance. HF was
iagnosed in 11.9%, 10.7%, 20.8%, and 9.0% of participants
sing Framingham, Boston, Gothenburg, and ESC criteria,
espectively. Prevalence figures increased with age but were
Table 1. Prevalence of Heart Failure Accordin
Gender
Total
n (%)
65–74
n (%)
Framingham 66 (11.9) 34 (9.0
p value
OR (95% CI)
Boston 59 (10.7) 32 (8.4
p value
OR (95% CI)
Gothenburg 115 (20.8) 67 (17.
p value
OR (95% CI)
ESC 50 (9.0) 15 (4.0
p value
OR (95% CI)
CI  confidence interval; ESC  European Society of Carimilar in men and women (Table 1). As shown by kappa
F
(alues between 0.05 and 0.59, the agreement between
iagnostic criteria ranged from poor to only moderate even
hen comparing criteria that yielded similar prevalence
Framingham, Boston, and ESC criteria) (Fig. 1).
onstruct validity. Participants diagnosed with Framing-
am, Boston, and Gothenburg criteria but not with ESC
riteria had an LVMI greater than those without HF;
ramingham criteria maximized the difference in LVMI
etween HF and non-HF participants (Fig. 2A). With all
riteria, HF participants had significantly lower LVEF than
on-HF participants; the difference was greater when the
iagnosis was made following ESC criteria (Fig. 2B). When
ASD was considered, only Framingham, Boston, and
othenburg criteria showed significant differences between
F and non-HF participants, slightly greater with Boston
riteria (Fig. 2C).
Gothenburg and ESC criteria failed to show any significant
ifference in physical functioning measures between HF and
on-HF participants. Conversely, when the diagnosis was
ased on Framingham or Boston criteria, HF participants
eported more difficulties in mobility tasks, had a lower SPS,
nd walked less at the 6MWT, even after adjusting for
ovariates (Fig. 3). The difference between HF and non-HF
articipants was maximized using Framingham criteria for
EMD (Fig. 3A) and SPS (Fig. 3B) and Boston criteria for
he 6MWT (Fig. 3C).
redictive validity. In a three-year follow-up, 18 cardiac
nd 29 noncardiac deaths were recorded (cumulative mor-
Different Diagnostic Criteria by Age and by
(yrs) Gender
75
n (%)
Men
n (%)
Women
n (%)
32 (18.4) 31 (13.4) 35 (10.9)
002 0.379
.4–3.8) 0.8 (0.5–1.3)
27 (15.5) 23 (9.9) 36 (11.2)
012 0.625
.2–3.4) 1.1 (0.7–2.0)
48 (27.6) 49 (21.1) 66 (20.6)
008 0.873
.2–2.7) 10 (0.6–1.5)
35 (20.1) 19 (8.2) 31 (9.7)
.001 0.553
.2–11.5) 1.2 (0.7–2.2)
; OR  odds ratio.g to
Age
)
0.
2.3 (1
)
0.
2.0 (1
7)
0.
1.8 (1
)
0
6.1 (3igure 1. Agreement between pairs of diagnostic criteria for heart failure
HF). ESC  European Society of Cardiology.
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October 19, 2004:1601–8 Validation of Heart Failure Diagnosis in the Elderlyality 8.5%). Cardiovascular mortality was 7.6%, 10.2%,
.5%, and 6.0% in participants labeled as HF using
ramingham, Boston, Gothenburg, and ESC criteria, re-
pectively. In Cox’s regression models adjusted for age,
ender, MMSE, GDS, and ICED, only Boston criteria
redicted cardiovascular death (Fig. 4).
Of the survivors, 446 who were not disabled at baseline
ere interviewed in the follow-up to detect changes in their
unctional status. New BADL disability was identified in 35
ases (7.8%). Cumulative incidence of BADL disability was
1.3%, 26.2%, 10.1%, and 26.5% in participants diagnosed
ith HF using Framingham, Boston, Gothenburg, and
SC criteria, respectively; the corresponding figures for
on-HF participants were 6.3%, 5.9%, 7.3%, and 6.3%. In
ogistic regression models, adjusted for age, gender,
MSE, GDS, and ICED, only Boston criteria predicted
ncident BADL disability (Table 2).
The absolute risk of HF-related hospital admission in the
ollow-up was 6.1%, 6.8%, 3.5%, and 0% in participants
ith and 0.6%, 0.6%, 0.7%, and 1.4% in those without the
iagnosis based on Framingham, Boston, Gothenburg, and
SC criteria, respectively. In adjusted logistic regression
odels, only Framingham and Boston criteria predicted a
ignificantly higher risk of HF-related hospital admissions;
he odds ratio was slightly higher for Boston than for
igure 2. Left ventricular mass index (LVMI) (A), ejection fraction
LVEF) (B), and left atrium systolic dimension (LASD) (C) were
ompared between participants with and without heart failure (HF)
ccording to different criteria. Data are least square means, adjusted for age
nd gender.  is the difference between non-HF and HF participants.
pen bars  non-HF; closed bars  HF. ESC  European Society of
ardiology; SEM  standard error of the mean.ramingham criteria (Table 3).
D
EISCUSSION
n this community-based sample of older persons, the
revalence of HF obtained with four sets of established
iagnostic criteria varied between 9.0% and 20.8%. Even
hen instruments that yielded similar prevalence were
ompared, the diagnostic agreement was only poor to
igure 3. Number of items with self-reported lower extremity mobility
ifficulty (LEMD) (A), lower extremity function summary performance
core (SPS) (B), and distance walked in 6 min (6MWT) (C) compared
etween participants with and without heart failure (HF) according to
ifferent criteria. Data are least square means, adjusted for age, gender,
ini Mental State Examination, Geriatric Depression Scale, and Index of
oexisting Diseases. Open bars  non-HF; closed bars  HF. ESC 
uropean Society of Cardiology; SEM  standard error of the mean.
igure 4. Cardiovascular mortality compared between participants with
nd without heart failure (HF) according to different criteria. Cox’s
roportional hazard survival models, adjusted for age, gender, Mini Mental
tate Examination, Geriatric Depression Scale, and Index of Coexisting
iseases. CI  confidence interval; CV  cardiovascular; ESC 
uropean Society of Cardiology; HR  hazard ratio.
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Validation of Heart Failure Diagnosis in the Elderly October 19, 2004:1601–8oderate. Because such a misclassification could have im-
ortant consequences in clinical practice and in epidemio-
ogic research, we deemed as necessary a compara-
ive validation of these diagnostic tools. Framingham and
oston criteria had better construct validity than Gothen-
urg and ESC criteria and also exhibited the closest diag-
ostic concordance. When predictive validity was eventually
aken into account, the Boston instrument was consistently
ssociated with a greater risk of cardiovascular death, inci-
ent BADL disability, and HF-related hospital admissions.
hus, our results indicate that Boston criteria are superior
or the diagnosis of HF in unselected older persons living in
he community.
Three of four criteria considered in this study had been
reviously validated, mostly in terms of concurrent criterion
alidity. Boston criteria were originally validated against a
apillary wedge pressure 12 mm Hg (21) and, subse-
uently, together with Framingham criteria, in a compara-
ive study against an LVEF 40% (41). Gothenburg
riteria were developed and validated in older men by
omparison with echocardiographic measures of LV func-
ion (22). Furthermore, the performance of these three
riteria was evaluated using the diagnosis of a cardiologist as
gold standard (42). Criteria from the ESC were derived
rom consensus and have not been previously validated.
The validation procedures followed in previous investi-
ations can be criticized. Heart failure is a clinical syndrome
ith multiple etiologies, diverse pathophysiology, and a
requently atypical presentation at older ages. Because of
hese characteristics, no single measure and, in particular, no
ingle hemodynamic abnormality can be taken as the refer-
nce standard to validate the diagnosis. Capillary wedge
able 2. Multivariate Prediction of Incident Disability in Basic
ctivities of Daily Living in Participants With a Baseline
iagnosis of Heart Failure According to Different Criteria
OR* 95% CI* p Value*
ramingham 2.4 0.8–6.8 0.102
oston 4.2 1.4–12.6 0.011
othenburg 1.1 0.4–3.2 0.826
SC 2.6 0.9–7.5 0.077
From separate logistic regression models, each adjusted for age, gender, Mini Mental
tate Examination, Geriatric Depression Scale, and Index of Coexisting Diseases.
Abbreviations as in Table 1.
able 3. Multivariate Prediction of Hospital Admissions for
eart Failure in Participants With a Baseline Diagnosis of
eart Failure According to Different Criteria
OR* 95% CI* p Value*
ramingham 6.9 1.3–36.1 0.022
oston 8.7 1.5–51.5 0.017
othenburg 5.1 0.9–27.7 0.058
SC NA NA NA
From separate logistic regression models, each adjusted for age, gender, Mini Mental
tate Examination, Geriatric Depression Scale, and Index of Coexisting Diseases. OR
ould not be calculated for ESC criteria because no participant with an ESC-basedf
iagnosis had hospital admissions due to heart failure in the follow-up.
NA  not applicable; other abbreviations as in Table 1.ressure commonly is increased in patients with HF, yet
fter diuretic or vasodilator treatment, it can be normal at
est and increase only on exertion. Left ventricular ejection
raction is low when HF is due to systolic dysfunction, but
y definition it is normal in the presence of diastolic
ysfunction. Finally, even cardiologists may disagree on the
resence of HF, at least in mildest cases and, therefore, the
udgment of a single clinician can be hardly assumed as a
old standard.
Following a different approach, we aimed at identifying
he instrument that would provide the best discrimination
etween participants labeled as HF versus non-HF across a
pectrum of measures pertinent to the two domains of
onstruct and predictive validity. In the domain of construct
alidity, LVEF, LVMI, and LASD were selected as indi-
ators of the underlying structural and functional abnormal-
ties of the heart. On average, LVEF is indeed expected to
e lower, and LVMI and LASD greater, in subjects with
F than in those without HF. Measures of physical
unctioning also were considered because the ultimate effect
f HF is to reduce blood supply to metabolically active
issues, such as skeletal muscles, therefore limiting physical
erformance. The three measures considered in the domain
f predictive validity represent expected consequences of
F, which reduces life expectancy, compromises functional
ndependence, and causes frequent hospitalizations. Because
hese outcomes are not exclusive of HF and can be due to a
ariety of conditions, the comparisons between HF and
on-HF participants were adjusted for demographics, co-
orbidity, and cognitive and affective status. Thus, our
alidation procedure encompassed thoroughly the clinical
omplexity of HF while controlling for a variety of possible
onfounders. We believe that this analytic approach and the
opulation-based nature of our sample represent major
trengths of this study. It should be further emphasized that,
o our knowledge, no previous study examined predictive
alidity of diagnostic criteria for HF.
The superiority of Boston criteria likely depends on their
ell-balanced scoring of history, physical findings, and
hest X-ray. However, it also should be pointed out that this
nstrument, although valid and preferable over the others
ested in this study, relies heavily on the presence of dyspnea
s the leading complaint. This symptom is neither specific
or sensitive for HF in older patients (43). On one hand,
hortness of breath is reported in the presence of many
oncardiac diseases (44), including a condition common but
sually overlooked in the elderly, such as thoracic kyphosis
45). On the other hand, in late life HF may present
typically, with a sudden decline of cognitive or physical
unctioning and negligible respiratory symptoms (46). We
ould argue that diagnostic criteria for HF, specifically
argeting older persons, should rely less on dyspnea and
ather include items on atypical presentations. Therefore,
he Boston criteria might be refined along this line, to
urther improve their diagnostic accuracy.
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nowledged. The study sample was relatively small, which
ight have limited the assessment of the validity for some of
he analyzed diagnostic criteria. On the other hand, it is
ikely that a larger sample size would have increased the
ifferences in performance of the diagnostic instruments,
herefore leaving the overall results of the study substantially
nchanged. Eligible residents in Dicomano who did not
articipate may pose a selection bias to data interpretation
ecause they were older than those who participated and
ore often were reported by their physicians as having HF.
owever, the accuracy of the diagnosis reported by primary
are physicians should be questioned because it did not rely
n uniform assessments and criteria. The mortality of
articipants labeled as HF was lower than expected in such
n old population, suggesting that milder forms of HF
revailed in participants who were assessed. Yet, this pos-
ibly reinforces the validity of our findings because mildest
ases are more difficult to recognize.
Even with these limitations, we believe that our findings
ave remarkable implications in the clinical and public
ealth fields. The demonstration that Boston criteria are
ore accurate than others may provide clinicians with an
nstrument of proven validity, therefore possibly overcoming
he difficulties they admittedly encounter in the diagnosis of
F in older persons. In the public health arena, these results
uggest that the Boston criteria should be preferred in future
pidemiologic surveys of HF. To some extent, they might
lso challenge the available information on HF epidemiol-
gy obtained with less accurate instruments.
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PPENDIX
or the Boston criteria for the diagnosis of heart failure,
lease see the October 20, 2004, issue of JACC at
ww.onlinejacc.org.
